Sp21 double mutant p. vivax dihydrofolate reductase in complex with des-chloropyrimethamine Deposition Author(s): Chitnumsub, P. , Khongsuk, P. , Kongsaeree, P. , Leartsakulpanich, U. , Tarnchompoo, B. , Walkinshaw, M.D. , Yuthavong, Y.
Date: 2005-03-03 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Plasmodium Vivax Sequences Data: 2BLC_A
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design Deposition Author(s): Fischer, P.M. , Gibson, D. , Kontopidis, G. , Mcinnes, C. , Mcnae, I. , Mezna, M. , Pandalaneni, S.R. , Thomas, M. , Walkinshaw, M.D. , Wang, S. , Wood, G.
Date: 2005-10-30 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 2C5N_A , 2C5N_C , 2C5N_B , 2C5N_D
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design Deposition Author(s): Fischer, P.M. , Gibson, D. , Kontopidis, G. , Mcinnes, C. , Mcnae, I. , Mezna, M. , Pandalaneni, S.R. , Thomas, M. , Walkinshaw, M.D. , Wang, S. , Wood, G.
Date: 2005-10-30 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 2C5O_A , 2C5O_C , 2C5O_B , 2C5O_D
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design Deposition Author(s): Fischer, P.M. , Gibson, D. , Kontopidis, G. , Mcinnes, C. , Mcnae, I. , Mezna, M. , Pandalaneni, S.R. , Thomas, M. , Walkinshaw, M.D. , Wang, S. , Wood, G.
Date: 2005-11-02 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 2C5V_A , 2C5V_C , 2C5V_B , 2C5V_D , 2C5V_F , 2C5V_H
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design Deposition Author(s): Fischer, P.M. , Gibson, D. , Kontopidis, G. , Mcinnes, C. , Mcnae, I. , Mezna, M. , Pandalaneni, S.R. , Thomas, M. , Walkinshaw, M.D. , Wang, S. , Wood, G.
Date: 2005-11-03 Method: X-RAY DIFFRACTION Resolution: 2.9 Å Organism(s): Homo Sapiens Sequences Data: 2C5X_A , 2C5X_C , 2C5X_B , 2C5X_D
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design Deposition Author(s): Fischer, P.M. , Gibson, D. , Kontopidis, G. , Mcinnes, C. , Mcnae, I. , Mezna, M. , Pandalaneni, S.R. , Thomas, M. , Walkinshaw, M.D. , Wang, S. , Wood, G.
Date: 2005-11-03 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Homo Sapiens Sequences Data: 2C5Y_A
Crystal structure of the catalytic domain of mos1 mariner transposase Deposition Author(s): Dawson, A. , Finnegan, D.J. , Richardson, J.M. , Taylor, P. , Walkinshaw, M.D.
Date: 2005-12-01 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Drosophila Mauritiana Sequences Data: 2F7T_A
Structure of hen egg white lysozyme soaked with ni2-xylylbicyclam Deposition Author(s): Hunter, T.M. , Mcnae, I.W. , Sadler, P.J. , Walkinshaw, M.D.
Date: 2006-06-10 Method: X-RAY DIFFRACTION Resolution: 1.75 Å Organism(s): Gallus Gallus Sequences Data: 2H9J_A
Structure of hen egg white lysozyme soaked with ni-cyclam Deposition Author(s): Hunter, T.M. , Mcnae, I.W. , Sadler, P.J. , Walkinshaw, M.D.
Date: 2006-06-10 Method: X-RAY DIFFRACTION Resolution: 1.75 Å Organism(s): Gallus Gallus Sequences Data: 2H9K_A
Crystal structure of phosphofructokinase apoenzyme from trypanosoma brucei. Deposition Author(s): Fothergill-Gilmore, L.A. , Martinez-Oyanedel, J. , Mcnae, I.W. , Walkinshaw, M.D.
Date: 2006-06-29 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Trypanosoma Brucei Sequences Data: 2HIG_A , 2HIG_B